BNP/CALL/MERCK & CO./130/0.1/20.12.24 Share Price

Warrant

DE000PE89AG5

Market Closed - Deutsche Boerse AG 20:50:32 31/05/2024 BST
0.61 EUR +1.67% Intraday chart for BNP/CALL/MERCK & CO./130/0.1/20.12.24
1 month-31.46%
3 months-29.07%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/05/24 0.61 +1.67%
30/05/24 0.6 -4.76%
29/05/24 0.63 -.--%
28/05/24 0.63 -21.25%
27/05/24 0.8 -1.23%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 08:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE89AG
ISINDE000PE89AG5
Date issued 16/02/2023
Strike 130 $
Maturity 20/12/2024 (201 Days)
Parity 10 : 1
Emission price 0.58
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.16
Lowest since issue 0.12
Delta0.47x
Omega 8.815
Premium8.87x
Gearing18.82x
Moneyness 0.9657
Difference Strike 4.46 $
Difference Strike %+3.43%
Spread 0.01
Spread %1.61%
Intrinsic value 0.000000

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW